Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Mar 11:16:1583986.
doi: 10.3389/fphar.2025.1583986. eCollection 2025.

Editorial: Metabolic reprogramming in cancer

Valentina Audrito  1 , Elisa Giovannetti  2   3
Affiliations
Editorial

Editorial: Metabolic reprogramming in cancer

Valentina Audrito et al. Front Pharmacol. .
No abstract available

Keywords: cancer; metabolic pathways; metabolic plasticity; metabolic reprogramming; metabolites; tumor microenvironment; tumorigenesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Metabolic reprogramming in cancer

Similar articles

See all similar articles

References

    1. Comandatore A., Franczak M., Smolenski R. T., Morelli L., Peters G. J., Giovannetti E. (2022). Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers. Semin. Cancer Biol. 86 (Pt 2), 93–100. 10.1016/j.semcancer.2022.09.001 - DOI - PubMed
    1. Hu T., Liu C.-H., Lei M., Zeng Q., Li L., Tang H., et al. (2024). Metabolic regulation of the immune system in health and diseases: mechanisms and interventions. Signal Transduct. Target. Ther. 9, 268. 10.1038/s41392-024-01954-6 - DOI - PMC - PubMed
    1. Nong S., Han X., Xiang Y., Qian Y., Wei Y., Zhang T., et al. (2023). Metabolic reprogramming in cancer: mechanisms and therapeutics. MedComm (2020) 4 (2), e218. 10.1002/mco2.218 - DOI - PMC - PubMed
    1. Xia L., Oyang L., Lin J., Tan S., Han Y., Wu N., et al. (2021). The cancer metabolic reprogramming and immune response. Mol. Cancer 20 (1), 28. 10.1186/s12943-021-01316-8 - DOI - PMC - PubMed

Publication types

LinkOut - more resources